FridayJan 27, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Anticipating ‘Best Year Ever’ in 2023

Lexaria Bioscience recently released its 2023 annual letter from CEO Chris Bunka, providing a strategic update to all stakeholders The letter highlights the key milestones achieved in calendar 2022, outlines expectations for calendar 2023, and indicates why Chris Bunka expects 2023 to be the company’s best year so far 1In calendar 2023, Lexaria expects to attain FDA registration for an investigational new drug (“IND”) program and commence Phase 1(b) clinical study evaluating the safety and tolerability of DehydraTECH(TM)-processed CBD as a treatment for hypertension The company will also be pursuing commercial relationships in 2023 even as its R&D continues to…

Continue Reading

WednesdayJan 25, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability to Meet Underserved Medical Needs

Bioavailability measures the amount of a substance that enters the bloodstream, with most oral routes providing lower amounts of the drug due to poor bioavailability Studies on nutrients show that not all the nutrients we ingest actually enter the bloodstream due to inhibiting factors in the digestive tract Lexaria’s patented DehydraTECH(TM) technology helps increase bioavailability for active pharmaceutical ingredients (“APIs”), which has been shown through various animal and human clinical studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is using its patented DehydraTECH(TM) technology to improve bioavailability and how active pharmaceutical ingredients (“APIs”) enter the bloodstream…

Continue Reading

MondayJan 23, 2023 10:30 am

Cepton, Inc. (NASDAQ: CPTN) Kicks off the New Year; Launches Vista(R)-X120 Plus — Ultra-Slim, Next-Gen Lidar for ADAS and Automotive Driving Applications

Built upon its predecessor–Vista-X90 lidar–that is being used in Cepton's flagship ADAS lidar program with GM and Koito, the Vista-X120 Plus is designed to significantly enhance lidar performance without compromising reliability, size, power efficiency, and cost Vista-X120 Plus advances the company's vision of enabling safe and autonomous transportation for everyone through mass-market lidar adoption. As a member of the Lidar Coalition, Cepton showcased its new product and a comprehensive portfolio of its lidar solutions at CES 2023, one of the most influential tech events in the world; the company demonstrated its adaptive 3D perception and simulations featuring a Chevy Silverado…

Continue Reading

WednesdayJan 18, 2023 9:00 am

Vision Energy Corp. (VENG) Announces Incorporation of New Dutch Subsidiaries to Accommodate Strategic Initiatives for Prospective Partners

Vision Energy has announced the incorporation of Vision Hydrogen BV as a project development company for its planned Ammonia Cracking Facility for back-cracking imported green ammonia into hydrogen gas as a service On December 2, 2022, Vision entered a Memorandum of Understanding with Linde Engineering with a mutual interest to participate in co-investment, development, and operations associated with hydrogen production through ammonia back-cracking Vision Energy has also incorporated “Evolution Terminals Operating BV,” a dedicated entity that will jointly own and operate logistics infrastructure The company’s Green Energy Hub is positioned to be the first terminal in Europe focused on green…

Continue Reading

ThursdayJan 12, 2023 11:15 am

Vision Energy Corp. (VENG) Files Application Initiating Formal Environmental Permit Assessment Process for Green Energy Hub Terminal Development Project in the Netherlands

Vision Energy is pioneering a Green Energy Hub terminal development project for the importation, storage, handling, and distribution of low-carbon renewable fuels and hydrogen carriers, including green ammonia, methanol, and biofuels The company intends to construct the development in phases, with Phase 1 accommodating 400,000 cubic meters of renewable liquid bulk storage and supporting infrastructure Vision Energy has engaged environmental experts and specialist Netherlands-based consultancy firms to undertake detailed studies to support final permit applications for the development Vision Energy (OTCQB: VENG), through its wholly owned subsidiary Evolution Terminals BV, is in the advanced stages of planning the construction of…

Continue Reading

WednesdayJan 11, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Adds to its Existing Suite of Global Patents with First Granted Patent in Canada

Lexaria has announced patent #3,093,414, its first patent in Canada, its 28th granted patent worldwide, and the first patent from its sixth patent family This patent joins the ranks of previously issued patents in Australia, India, Japan, and the EU, even as similar patent applications for skin-based delivery of patented DehydraTECH formulations remain pending in many countries In Lexaria’s 2018 study, DehydraTECH-processed CBD demonstrated almost a 1,900% increase in CBD permeability through human skin compared to a control formulation that was devoid of any commercial penetration enhancers This patent inches Lexaria closer to taking advantage of the cosmeceuticals market, projected…

Continue Reading

TuesdayJan 10, 2023 12:00 pm

Aditxt, Inc. (NASDAQ: ADTX) Bolsters Goal to Conduct First-In-Human Clinical Trial Evaluating ADI(TM) Tech with Formation of Adimune, Inc. Subsidiary; Appoints Industry Veteran as Subsidiary Chairman and CEO

Aditxt recently announced the formation of a U.S.-based wholly owned subsidiary, Adimune, Inc., and appointed Joachim-Friedrich Kapp, M.D., Ph.D., a 30-year veteran of the pharmaceutical industry, as its Chairman and CEO Dr. Kapp will be tasked with leading and developing the Apoptotic DNA Immunotherapy(TM) (“ADI(TM)”) technology toward clinical trials Aditxt also plans to submit a Clinical Trial Application (“CTA”) for immunotherapeutic technology drug candidate ADI(TM)-100, seeking approval for Adimune(TM) to conduct the first-in-human study in psoriasis patients, beginning in the second half of 2023 ADI(TM) is a nucleic acid-based technology platform that utilizes a novel antigen-specific approach to induce immune…

Continue Reading

MondayJan 09, 2023 9:45 am

Vision Energy Corp. (VENG) Subsidiary Pioneering a Green Energy Hub in the North Sea Port of Vlissingen, The Netherlands

A total of 194 parties (including the European Union) have joined the Paris Agreement intending to reach carbon-neutral status by 2050 to reduce the impact of global climate change Vision Energy’s Green Energy Hub in the Netherlands will help with import, storage, and distribution of low-carbon renewable fuels and hydrogen carriers The company plans for first operations to commence in 2026, with the terminal running 24 hours a day, 365 days a year Climate change is a global emergency with negative impacts beyond national borders – requiring cooperation and collaborative solutions amongst nations and world leaders. The Paris Agreement is…

Continue Reading

FridayJan 06, 2023 11:15 am

Flora Growth Corp. (NASDAQ: FLGC) Acquisition of Franchise Global Health Completed, Rapid Jump in Potential for European Cannabis Sales

International cannabis operator Flora Growth Corp. is rapidly expanding its global footprint and Colombia-based international supply chain thanks to strategic acquisitions during the past several months Flora’s most recent acquisition was concluded just before Christmas on finalization of an agreement with multi-national operator Franchise Global Health Inc. that strengthens Flora’s position in Europe Franchise Global Health (“FGH”) serves 1,200 pharmacies in Germany, which the companies regard as the doorway to the rest of Europe, and it also has a footprint in Portugal and Denmark, while Flora Growth has completed exports to Switzerland and the Czech Republic Flora reported a 604…

Continue Reading

ThursdayJan 05, 2023 9:00 am

Vision Energy Corp. (VENG) Expands Project Management and Development Team, Advancing Green Energy Hub Project in North Sea Port of Vlissingen

Through their ETBV project in Europe, renewable energy developer Vision Energy is continuing its work to realize project development objectives and has increased its core team of commercial and engineering professionals for its Green Energy Hub project The company’s Project Management and Consultancy (“PMC”) team, with decades of experience working with major industry operators, has collectively developed over 8 million cubic meters of bulk storage capacity worldwide The Green Energy Hub project is strategically located in the North Sea port of Vlissingen at the mouth of the Westerschelde estuary in the Netherlands, and is positioned to be the first terminal…

Continue Reading

Contact us: (310) 299-1717